Marc Oczachowski – CEO, EDAP TMS, France
Marc Oczachowski, CEO of EDAP TMS, a French medtech and global leader in therapeutic ultrasound, elaborates on the history of the company while discussing their newest innovation for the noninvasive…
Address: 37 rue Saint-Romain, 69008 Lyon,France
Tel: +33 (0)4 72 78 25 25
Web: http://www.merck.fr/fr/index.html;jsessionid=264C78DA1A1A6E632FADB2287B91481F
Merck France is compose of several divisions:
Merck Santé: Commercializes branded medicines developed by the group Merck’s own research at international level
Merck Serono: Commercializes the group’s branded prescription drug products in France.
Merck Serono Biodevelopment S.A.S.: Development of the production process, analytical and purification laboratories and Good Manufacturing Practice production and is at the frontier between research and manufacturing.
Théramex S.A.M.: Women’s health Products
Merck Medication Familiale: Home Healthcare Products
Merck Chimie S.A.S.: Sale & marketing organization, being part of the chemical branch of the Merck Group
Therapeutics
Oncology
Neurology
Fertility
Endocrinology
CardioMetabolic
Dermatology
Emergency products
Alcology
Gynecology
OTC
API
Marc Oczachowski, CEO of EDAP TMS, a French medtech and global leader in therapeutic ultrasound, elaborates on the history of the company while discussing their newest innovation for the noninvasive…
In an exclusive interview, Dominique Le Guludec, president of the French National Authority for Health (Haute Autorité de Santé (HAS)), offers her insider comments on the changes in French healthcare…
David Lescuyer, managing director of Skyepharma, a specialized CDMO, reflects on the past three years of the company as it transitioned from a drug delivery platform to a fully-fledged service…
Dr Marc-Alexander Burmeister, president of B. Braun in France, shares the exciting changes to come for B. Braun globally and in France, and discusses the shifting environment of healthcare in…
Françoise Alliot-Launois, VP of the French League Against Rheumatism (AFLAR), discusses the issues around bone and joint infections in France, AFLAR’s work to help patients suffering from these diseases, and…
Finn Søndergaard, CEO of Intsel Chimos, shares the motivation behind the company’s two recent acquisitions of Diverchim and Centre Lab, and the new strategic opportunities to expand as a full-service…
Abbvie France’s Pierre-Claude Fumoleau outlines his strategic priorities for the affiliate, AbbVie’s unique corporate culture and ethos, and how he envisions upcoming regulatory reforms playing out in France. We…
Denis Delval, CEO of iconic French pharma firm LFB since December 2017, discusses his key priorities to build the new LFB. My vision is that we should be strong…
Biotest’s Olivier Samama outlines the changes that the takeover of the company has had on the French affiliate, the country’s plasma market and pricing policy. The product offering remains…
Edouard Bieth, managing director of Tillotts Pharma in France, discusses the opportunities and challenges of opening an affiliate in the country and the uniqueness of Tillotts’ specialization in gastrointestinal drugs.…
The healthcare and life sciences industries, as they become more advanced and complex, increasingly require government involvement to ensure clinical compliance, ethical behaviour and the well-being of the nation. The health sector is…
Arnaud Gobet, president of Innothera, discusses how the company balances its unique and diverse offering of medical devices, hygiene and protection products and pharmaceuticals, Innothera’s burgeoning international footprint and the…
See our Cookie Privacy Policy Here